Inflammation is the body’s defence system, a way of responding to injury or infection. One key molecule involved in the ...

Researchers in Japan are exploring a future where the body itself becomes a health monitor, no screens or batteries required.

“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...

Study findings suggest that the ratio of interleukin-10 to tumor necrosis factor-alpha produced by transitional-1 B cells can predict renal allograft outcomes with a lead time of about 8 months.

A new study published in the journal Science Signaling has found that an immune system protein plays a central role in the ...

A team of researchers in the United States has discovered a novel mechanism in which a key protein drives the inflammatory damage associated with rheumatoid arthritis. The foundational finding is ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today ...

ACR20: American College of Rheumatology Criteria of 20% improvement; PsARC: Psoriatic Arthritis Response Criteria; PASI: Psoriasis Area and Severity Index. TNF inhibitors can induce remission and ...

NEW YORK (Reuters Health) - Patients with rheumatoid arthritis who fail to respond to one of the biological drugs will often have a better response to a second drug within the same class, Danish ...